![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
ABSTRACT
Introduction: Silibinin is mixture of flavonolignans extracted from milk thistle and often has been used in the treatment of acute and chronic liver disorders caused by toxins, drug, alcohol and hepatitis and gall bladder disorders for its antioxidant and hepatoprotective properties.
Areas covered: However, increasing evidence suggest that silibinin is not solely limited in the treatment of these diseases. Further research suggests that silymarin may function diversely and may serve as a novel therapy for cancer therapy, such as lung cancer, prostatic cancer, colon cancer, breast cancer, bladder cancer and hepatocellular carcinoma by regulating cancer cells growth, proliferation, apoptosis, angiogenesis and many other mechanism.
Expert commentary: In this review, in order to provide potential new treatment for these cancer, we summarize the recent anti-cancer findings of silibinin in these cancer and clarify the mechanisms of this effect.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Additional information
Funding
Notes on contributors
Xing-Xing Zhu
Lin-Yan Qian, Hai Zou and Xing-Xing Zhu planned the article and contributed to data collection, discussing content, writing and reviewing the article. Qiang He, Ya-Hui Ding and Yi Wu conceived the article and participated in its design and helping to writing the article.
Ya-Hui Ding
Lin-Yan Qian, Hai Zou and Xing-Xing Zhu planned the article and contributed to data collection, discussing content, writing and reviewing the article. Qiang He, Ya-Hui Ding and Yi Wu conceived the article and participated in its design and helping to writing the article.
Yi Wu
Lin-Yan Qian, Hai Zou and Xing-Xing Zhu planned the article and contributed to data collection, discussing content, writing and reviewing the article. Qiang He, Ya-Hui Ding and Yi Wu conceived the article and participated in its design and helping to writing the article.
Lin-Yan Qian
Lin-Yan Qian, Hai Zou and Xing-Xing Zhu planned the article and contributed to data collection, discussing content, writing and reviewing the article. Qiang He, Ya-Hui Ding and Yi Wu conceived the article and participated in its design and helping to writing the article.
Hai Zou
Lin-Yan Qian, Hai Zou and Xing-Xing Zhu planned the article and contributed to data collection, discussing content, writing and reviewing the article. Qiang He, Ya-Hui Ding and Yi Wu conceived the article and participated in its design and helping to writing the article.
Qiang He
Lin-Yan Qian, Hai Zou and Xing-Xing Zhu planned the article and contributed to data collection, discussing content, writing and reviewing the article. Qiang He, Ya-Hui Ding and Yi Wu conceived the article and participated in its design and helping to writing the article.